Skip to content
    Back to Database
    NootropicsSynthetic

    Caffeine Anhydrous

    Also known as: Caffeine, 1,3,7-trimethylxanthine

    Methylxanthine alkaloid; non-selective adenosine A1/A2A receptor antagonist; raises cAMP, catecholamine release, and Ca²⁺ sensitivity in muscle.

    Last reviewed: 2026-06-23 · 1 indexed study

    Evidence Score
    90/100
    EnergyFocusEndurance performanceStrength performanceFat oxidation
    Data Completeness3/4 · 75%
    Evidence ScoreDosageSafetyLinked Studies

    Set your location for accurate regulatory status

    Saved on this device — no sign-in needed.

    Overview

    Caffeine anhydrous is the most extensively studied ergogenic aid, antagonising adenosine receptors to reduce perceived effort and improve endurance, strength, and cognitive performance.

    Mechanism & Function

    Mechanism of Action

    Reduces perceived effort, increases motor unit recruitment, mobilises fatty acids, and enhances vigilance/reaction time.

    Physiological Role

    Robust ergogenic effects across endurance (~3–5% performance), strength (modest), sprint (modest), and cognition (large) at 3–6 mg/kg pre-exercise.

    Primary Pathways

    Adenosine A1/A2A antagonismCatecholamine releasecAMP/PDE signallingRyR1 Ca²⁺ sensitivity

    Performance / Health Relevance

    Hundreds of RCTs and multiple meta-analyses across endurance, strength, sprint, team sport, and cognitive endpoints.

    Evidence Review

    Overall90/100
    Human Clinical95/100
    Meta-Analysis92/100
    Mechanistic92/100
    Real-World90/100
    Safety88/100

    Practical Use & Dosage

    Minimum Effective Dose
    100 mg
    Optimal Range
    3–6 mg/kg 30–60 min pre-exercise
    Upper / Caution Level
    ~9 mg/kg (diminishing returns and side effects)
    Timing
    30–60 min pre-exercise/task; avoid within 6 h of bed
    Best Format
    Powder, tablet, capsule
    Bioavailability
    ~99% — peak plasma 30–60 min.
    Absorption Considerations
    Rapid passive intestinal absorption.

    Safety & Interactions

    Side Effects

    • •Jitters
    • •Insomnia
    • •Tachycardia
    • •Anxiety
    • •GI upset

    Contraindications

    • Severe anxiety disorders
    • Uncontrolled hypertension
    • Pregnancy >200 mg/day

    Drug Interactions

    • •MAOIs
    • •Stimulants
    • •Clozapine
    • •Theophylline

    Who Should Avoid

    • •Cardiac arrhythmias
    • •Severe anxiety

    Monitoring

    Heart rate, BP in sensitive users.

    Frequently Asked Questions

    Auto-generated from indexed evidence — dosage, safety, interactions, and more.

    When is Caffeine Anhydrous typically used or indicated?

    Caffeine Anhydrous is most commonly used for: Energy, Focus, Endurance performance, Strength performance, Fat oxidation. Robust ergogenic effects across endurance (~3–5% performance), strength (modest), sprint (modest), and cognition (large) at 3–6 mg/kg pre-exercise.

    How does Caffeine Anhydrous work?

    Reduces perceived effort, increases motor unit recruitment, mobilises fatty acids, and enhances vigilance/reaction time.

    What is the recommended dose of Caffeine Anhydrous?

    The optimal range is 3–6 mg/kg 30–60 min pre-exercise. with a minimum effective dose of 100 mg. Best taken: 30–60 min pre-exercise/task; avoid within 6 h of bed. Upper / caution level: ~9 mg/kg (diminishing returns and side effects).

    What are the side effects of Caffeine Anhydrous?

    Reported side effects include: Jitters; Insomnia; Tachycardia; Anxiety; and GI upset. Monitoring: Heart rate, BP in sensitive users.

    Does Caffeine Anhydrous interact with medications?

    Known or theoretical interactions: MAOIs; Stimulants; Clozapine; and Theophylline. Always check with a clinician before combining with prescription medication.

    Who should avoid Caffeine Anhydrous?

    Caffeine Anhydrous is generally not recommended for: Cardiac arrhythmias; Severe anxiety; Severe anxiety disorders; Uncontrolled hypertension; and Pregnancy >200 mg/day.

    How strong is the evidence for Caffeine Anhydrous?

    Evidence level: Strong (overall score 90/100), based on 1 indexed study on SuppIndex.

    Research & References (1)

    Caffeine and exercise performance: international position stand

    Systematic Review2021Strong
    PubMed

    Robust ergogenic effects; 3–6 mg/kg optimal; individual genetic variation in response.

    Trademark Ingredients

    Related Ingredients

    Other top-rated ingredients in Nootropics.

    Research Overview

    Strong Evidence
    1Total Studies
    0Human Trials
    0Meta-Analyses
    2021Latest Study
    0Animal / In Vitro
    1Athlete Studies
    Primary data sourceAthletes
    Pooled evidence (meta-analysis / systematic review)Yes
    Athlete-specific data1 studies

    Cite this ingredient

    One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.

    Stable URL

    https://thesuppindex.com/ingredients/caffeine-anhydrous

    SuppIndex. (2026). Caffeine Anhydrous: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/caffeine-anhydrous

    Based on 1 indexed studies · Evidence level: Strong.

    Goal Ratings

    Endurance
    Focus
    Cognition
    Strength
    Fat Loss

    Stack Compatibility

    Pairs with L-theanine (smoother focus), beta-alanine (pre-workout), creatine. Cycle to avoid tolerance.